--- title: "This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday" type: "News" locale: "en" url: "https://longbridge.com/en/news/291796157.md" description: "Top Wall Street analysts initiated coverage on several stocks with bullish outlooks. Evercore ISI rated EROC Outperform ($28 target), JP Morgan rated WSE Overweight ($17.50 target), Goldman Sachs rated FRBT Buy ($23.50 target), B of A rated PBLS Buy ($45 target), and Stifel rated WHK Buy ($30 target). These initiations highlight positive analyst sentiment for Monday's trading." datetime: "2026-07-06T11:11:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291796157.md) - [en](https://longbridge.com/en/news/291796157.md) - [zh-HK](https://longbridge.com/zh-HK/news/291796157.md) generator: "portal-rs" --- # This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. - Evercore ISI Group analyst Nicholas Amicucci initiated coverage on **ERock** (NYSE:EROC) with an Outperform rating and announced a price target of $28. ERock shares closed at $15.47 on Thursday. See how other analysts view this stock. - JP Morgan analyst Craig McDowell initiated coverage on **Wise Group PLC** (NASDAQ:WSE) with an Overweight rating and announced a price target of $17.5. Wise Group shares closed at $12.95 on Thursday. See how other analysts view this stock. - Goldman Sachs analyst Sahar Islam initiated coverage on **Forbright** (NASDAQ:FRBT) with a Buy rating and announced a price target of $23.5. Forbright shares closed at $18.75 on Thursday. See how other analysts view this stock. - B of A Securities analyst Tazeen Ahmad initiated coverage on **Parabilis Medicines** (NASDAQ:PBLS) with a Buy rating and announced a price target of $45. Parabilis Medicines shares closed at $29.58 on Thursday. See how other analysts view this stock. - Stifel analyst Selman Akyol initiated coverage on **Whitehawk Minerals Corp** (NYSE:WHK) with a Buy rating and announced a price target of $30. WhiteHawk Minerals shares closed at $27.37 on Thursday. See how other analysts view this stock. Considering buying PBLS stock? Here’s what analysts think: *Photo via Shutterstock* ### Related Stocks - [WSE.US](https://longbridge.com/en/quote/WSE.US.md) - [FRBT.US](https://longbridge.com/en/quote/FRBT.US.md) - [EROC.US](https://longbridge.com/en/quote/EROC.US.md) - [PBLS.US](https://longbridge.com/en/quote/PBLS.US.md) - [WHK.US](https://longbridge.com/en/quote/WHK.US.md) - [WISE.UK](https://longbridge.com/en/quote/WISE.UK.md) - [SSTK.US](https://longbridge.com/en/quote/SSTK.US.md) ## Related News & Research - [Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Average Recommendation of "Buy" by Analysts](https://longbridge.com/en/news/294577377.md) - [22:17 ETWSE Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Wise Group plc](https://longbridge.com/en/news/296424557.md) - [Major Insider Move Signals Growing Confidence in Parabilis Medicines](https://longbridge.com/en/news/293551262.md) - [Major Investor Makes Bold Move in Parabilis Medicines, Inc. Stock](https://longbridge.com/en/news/291219072.md) - [MEDI: Record sales and profit in Q2/H1 2026, with strong growth in own products and key regions](https://longbridge.com/en/news/296576263.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**